| Trial registration number
|
NCT05670444 |
Full text link
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05670444
|
First author
Last imported at : March 31, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
Riadh Boukef
|
Contact
Last imported at : March 31, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
2023-01-04
|
Recruitment status
Last imported at : March 31, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : March 31, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
patients aged less than 60 years old
no previous medical history
consulting the emergency department for covid and covid-like illness
not hospitalized
|
Exclusion criteria
Last imported at : March 31, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
allergy or severe side effect on the study drugs
refused to consent
pregnant women
|
Number of arms
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Hôpital Universitaire Sahloul
|
Inclusion age min
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
60
|
Countries
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Tunisia
|
Type of patients
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Mild disease at enrollment
|
Severity scale
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
1: Mild disease at enrollment
|
Total sample size
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
150
|
primary outcome
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
combined outcome;mortality rate;need for ICU admission
|
Notes
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
Phase 1
|
Arms
Last imported at : Jan. 5, 2023, 4 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "nan", "treatment_id": 2677, "treatment_name": "Melatonin+multimineral+vitamin c+vitamin d+zinc", "treatment_type": "Central nervous system agents+vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|